Nabil Asaad, PhD

Senior Associate

Nabil Asaad, PhD

Nabil specialises in IP and regulatory advice for clients ranging from start-ups to global players, with a particular focus on the life sciences and other technology-rich sectors.

Nabil provides pragmatic, commercially-minded advice with a focus on intellectual property strategy and regulatory compliance. In addition to advice on the identification, protection, commercialisation and enforcement of IP rights, Nabil supports clients with commercial contracts, due diligence, and regulatory compliance.

Prior to training as a solicitor, Nabil worked in early phase pharmaceutical R&D for AstraZeneca and chaired the Physical Organic Chemistry Group of the Royal Society of Chemistry.

Show full CV Hide full CV

Latest news & insights

Laboratory pipettes
Life sciences & healthcare

Advising IP Group on option exercise to accelerate development of first-in-class gene therapy for patients with cystic fibrosis

29 October 2021

by Colin McCall and Nabil Asaad, PhD

Click here to find out more
White microscope on yellow background
Life sciences & healthcare

Electronic instructions for use of medical devices - Requirements under new Implementing Regulation (EU) 2021/2226

18 May 2022
In-depth analysis

by Irina Rebin

Click here to find out more
Blood samples
Life sciences & healthcare

Telehealth advertising admissible if accepted professional standards are observed

18 May 2022
Briefing

by Dr. Daniel Tietjen

Click here to find out more
chameleon skin
Life sciences & healthcare

TAMG – the new Veterinary Medicinal Products Act

18 May 2022
Briefing

by Dr. Daniel Tietjen

Click here to find out more

Related people

Meet me at

There are no upcoming events